Cheung, Nai-Kong

Publications

Sort by

Co-Author Network

selected publications

Immunotherapy with anti-G_D2 monoclonal antibody in infants with high-risk neuroblastoma. International journal of cancer. 2022 Academic Article GET IT
Bispecific antibodies for the treatment of neuroblastoma. Pharmacology & therapeutics. 2022 Review GET IT
Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research. 2022 Academic Article GET IT
Times cited: 3
Expression Analysis of GD2 by Immunohistochemistry in Invasive Breast Carcinoma: Clinical and Pathologic Correlation. Applied immunohistochemistry & molecular morphology : AIMM. 2022 Academic Article GET IT
Times cited: 1
Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies. Journal for immunotherapy of cancer. 2022 Academic Article GET IT
Times cited: 2
Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins. International journal of molecular sciences. 2021 Academic Article GET IT
Times cited: 7
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma. Cancers. 2021 Academic Article GET IT
Times cited: 93
Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor. Frontiers in oncology. 2021 Review GET IT
Times cited: 2
Reciprocal impacts of telomerase activity and ADRN/MES differentiation state in neuroblastoma tumor biology. Communications biology. 2021 Academic Article GET IT
Times cited: 1
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis. Molecular cancer therapeutics. 2021 Academic Article GET IT
Times cited: 2
Human Cytomegalovirus Infection Promotes Expansion of a Functionally Superior Cytoplasmic CD3⁺ NK Cell Subset with a Bcl11b-Regulated T Cell Signature. Journal of immunology (Baltimore, Md. : 1950). 2021 Academic Article GET IT
Times cited: 1
KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up. Pediatric blood & cancer. 2021 Academic Article GET IT
Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response. Journal of hematology & oncology. 2021 Academic Article GET IT
Times cited: 15
Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy. Journal for immunotherapy of cancer. 2021 Academic Article GET IT
Times cited: 11
Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAM. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2021 Academic Article GET IT
Times cited: 1
Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release. Journal for immunotherapy of cancer. 2021 Academic Article GET IT
Times cited: 12
T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia. Journal for immunotherapy of cancer. 2021 Academic Article GET IT
Times cited: 2
Potent antitumor effect of T cells armed with anti-GD2 bispecific antibody. Pediatric blood & cancer. 2021 Academic Article GET IT
Times cited: 5
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications. Bioconjugate chemistry. 2021 Academic Article GET IT
Times cited: 5
Differential Impact of ALK Mutations in Neuroblastoma. JCO precision oncology. 2021 Academic Article GET IT
A novel multimeric IL15/IL15Rα-Fc complex to enhance cancer immunotherapy. Oncoimmunology. 2021 Academic Article GET IT
Times cited: 7
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. Nature cancer. 2021 Academic Article GET IT
Times cited: 48
Correction to An N-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy. Bioconjugate chemistry. 2021 Article GET IT
Times cited: 1
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 41
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma. Journal of hematology & oncology. 2020 Academic Article GET IT
Times cited: 30
Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy. Frontiers in oncology. 2020 Editorial Article GET IT
Times cited: 1
Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies. Journal for immunotherapy of cancer. 2020 Academic Article GET IT
Times cited: 4
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 32
Cancer immunotherapy via targeted TGF-β signalling blockade in T_H cells. Nature. 2020 Academic Article GET IT
Times cited: 115
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations. Nature communications. 2020 Academic Article GET IT
Times cited: 59
IntraOmmaya compartmental radioimmunotherapy using ¹³¹I-omburtamab-pharmacokinetic modeling to optimize therapeutic index. European journal of nuclear medicine and molecular imaging. 2020 Academic Article GET IT
Times cited: 8
A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Comment GET IT
Times cited: 9
Alpha radioimmunotherapy using ²²⁵Ac-proteus-DOTA for solid tumors - safety at curative doses. Theranostics. 2020 Academic Article GET IT
Times cited: 16
Characterizing and classifying neuroendocrine neoplasms through microRNA sequencing and data mining. NAR cancer. 2020 Academic Article GET IT
Times cited: 10
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma. Pediatric blood & cancer. 2020 Academic Article GET IT
Times cited: 5
Targets and Antibody Formats for Immunotherapy of Neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Review GET IT
Times cited: 63
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies. Science translational medicine. 2020 Academic Article GET IT
Times cited: 38
An N-Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy. Bioconjugate chemistry. 2020 Academic Article GET IT
Times cited: 13
Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies. Cancer immunology research. 2020 Review GET IT
Times cited: 35
ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures. Cancer cell. 2019 Academic Article GET IT
Times cited: 38
Silencing Fc Domains in T cell-Engaging Bispecific Antibodies Improves T-cell Trafficking and Antitumor Potency. Cancer immunology research. 2019 Academic Article GET IT
Times cited: 31
Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma. Pediatric blood & cancer. 2019 Academic Article GET IT
Times cited: 3
Biodistribution and Dosimetry of Intraventricularly Administered ¹²⁴I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2019 Academic Article GET IT
Times cited: 21
Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma. Frontiers in oncology. 2019 Review GET IT
Times cited: 141
Telomere Trimming and DNA Damage as Signatures of High Risk Neuroblastoma. Neoplasia (New York, N.Y.). 2019 Academic Article GET IT
Times cited: 9
Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes. 2019 GET IT
Times cited: 17
Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial. International journal of radiation oncology, biology, physics. 2019 Academic Article GET IT
Times cited: 9
Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical Trial. JAMA oncology. 2018 Academic Article GET IT
Times cited: 67
Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma. Theranostics. 2018 Academic Article GET IT
Times cited: 26
Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers. Molecular cancer therapeutics. 2018 Academic Article GET IT
Times cited: 27
Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study. Pediatric blood & cancer. 2018 Academic Article GET IT
Times cited: 9
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial. The Lancet. Oncology. 2018 Academic Article GET IT
Times cited: 161
A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia. Blood advances. 2018 Academic Article GET IT
Times cited: 31
Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study. Oncoimmunology. 2018 Academic Article GET IT
Times cited: 54
Treatment and outcome of adult-onset neuroblastoma. International journal of cancer. 2018 Academic Article GET IT
Times cited: 18
Dose-escalation is needed for gross disease in high-risk neuroblastoma. Pediatric blood & cancer. 2018 Academic Article GET IT
Times cited: 17
TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies. JCI insight. 2018 Academic Article GET IT
Times cited: 25
Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?. International journal of radiation oncology, biology, physics. 2018 Academic Article GET IT
Times cited: 18
Targeting Intracellular Antigens with pMHC-Binding Antibodies: A Phage Display Approach. Methods in molecular biology (Clifton, N.J.). 2018 Academic Article GET IT
Genotyping Natural Killer Immune Checkpoints to Discover Biomarkers of Response. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Comment GET IT
Times cited: 2
Erratum to 'Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies' [Cancer Treat. Rev. 58C (2017) 22-33]. Cancer treatment reviews. 2017 Academic Article GET IT
Times cited: 3
Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk Neuroblastoma. Journal of pediatric hematology/oncology. 2017 Academic Article GET IT
Times cited: 9
A phase II study of radioimmunotherapy with intraventricular ¹³¹ I-3F8 for medulloblastoma. Pediatric blood & cancer. 2017 Academic Article GET IT
Times cited: 40
Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma. Theranostics. 2017 Academic Article GET IT
Times cited: 13
MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G_D2 immunotherapy. Oncotarget. 2017 Academic Article GET IT
Times cited: 8
T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics. Pharmacology & therapeutics. 2017 Review GET IT
Times cited: 80
Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival. Oncoimmunology. 2017 Academic Article GET IT
Times cited: 23
Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2017 Academic Article GET IT
Times cited: 34
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors. PloS one. 2017 Academic Article GET IT
Times cited: 28
Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies. Cancer treatment reviews. 2017 Review GET IT
Times cited: 66
Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2. Oncoimmunology. 2017 Academic Article GET IT
Times cited: 27
Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies. Cancer letters. 2017 Review GET IT
Times cited: 37
Acute myeloid leukemia targets for bispecific antibodies. Blood cancer journal. 2017 Academic Article GET IT
Times cited: 4
Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8. Journal of controlled release : official journal of the Controlled Release Society. 2017 Academic Article GET IT
Times cited: 33
Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody. Oncoimmunology. 2017 Academic Article GET IT
Times cited: 57
Acute myeloid leukemia targets for bispecific antibodies. Blood cancer journal. 2017 Review GET IT
Times cited: 34
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study. Pediatric blood & cancer. 2017 Academic Article GET IT
Times cited: 39
Temporal stability and molecular persistence of the bone marrow plasma cell antibody repertoire. Nature communications. 2016 Academic Article GET IT
Times cited: 11
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma. International journal of cancer. 2016 Academic Article GET IT
Times cited: 38
Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults. Pediatric blood & cancer. 2016 Academic Article GET IT
Times cited: 94
Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma. International journal of radiation oncology, biology, physics. 2016 Academic Article GET IT
Times cited: 32
Antitumor Efficacy of Anti-GD2 IgG1 Is Enhanced by Fc Glyco-Engineering. Cancer immunology research. 2016 Academic Article GET IT
Times cited: 14
Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors. Oncoimmunology. 2016 Academic Article GET IT
Times cited: 27
KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 58
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin. Oncotarget. 2016 Academic Article GET IT
Times cited: 48
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016 Academic Article GET IT
Times cited: 15
ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT. Oncogene. 2015 Academic Article GET IT
Times cited: 81
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates. European journal of nuclear medicine and molecular imaging. 2015 Academic Article GET IT
Times cited: 33
Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3. The Journal of biological chemistry. 2015 Academic Article GET IT
Times cited: 73
A distinct gene expression signature characterizes human neuroblastoma cancer stem cells. Stem cell research. 2015 Academic Article GET IT
Times cited: 35
Immunotherapy of Childhood Sarcomas. Frontiers in oncology. 2015 Review GET IT
Times cited: 1568
Radioimmunotherapy of human tumours. Nature reviews. Cancer. 2015 Review GET IT
Times cited: 318
Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G_D2 immunotherapy and isotretinoin: a prospective Phase II study. Oncoimmunology. 2015 Academic Article GET IT
Times cited: 15174
A dual-specific anti-IGF-1/IGF-2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma. International journal of cancer. 2015 Academic Article GET IT
Times cited: 18
Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential. Leukemia. 2015 Academic Article GET IT
Times cited: 66
Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy. Journal of neuro-oncology. 2015 Academic Article GET IT
Times cited: 20
Human derived dimerization tag enhances tumor killing potency of a T-cell engaging bispecific antibody. Oncoimmunology. 2015 Academic Article GET IT
Times cited: 145
Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8. The Journal of biological chemistry. 2015 Academic Article GET IT
Times cited: 27
Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells. Oncoimmunology. 2015 Academic Article GET IT
Times cited: 134
Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology. Pediatric blood & cancer. 2015 Review GET IT
Times cited: 10
Osteochondroma in long-term survivors of high-risk neuroblastoma. 2015 GET IT
Times cited: 12
Disialoganglioside GD2 as a therapeutic target for human diseases. Expert opinion on therapeutic targets. 2015 Review GET IT
Times cited: 113
Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Academic Article GET IT
Times cited: 35
Desmoplastic small round cell tumor 20 years after its discovery. Future oncology (London, England). 2015 Academic Article GET IT
Times cited: 32
Generation of TCR-Like Antibodies Using Phage Display. Methods in molecular biology (Clifton, N.J.). 2015 Academic Article GET IT
Times cited: 5
Retargeting T cells to GD2 pentasaccharide on human tumors using Bispecific humanized antibody. Cancer immunology research. 2014 Academic Article GET IT
Times cited: 58
When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Letter GET IT
Times cited: 7
Antibody induced pain in children: An opportunity to study pain mechanism, IgG design and analgesics. Pediatric blood & cancer. 2014 Comment GET IT
Structure Based Refinement of a Humanized Monoclonal Antibody That Targets Tumor Antigen Disialoganglioside GD2. Frontiers in immunology. 2014 Academic Article GET IT
Times cited: 24
GD2-targeted immunotherapy and radioimmunotherapy. Seminars in oncology. 2014 Review GET IT
Times cited: 63
Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy. International journal of cancer. 2014 Academic Article GET IT
Times cited: 32
Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex. Molecular cancer therapeutics. 2014 Academic Article GET IT
Times cited: 46
Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis. Genes, chromosomes & cancer. 2014 Academic Article GET IT
Times cited: 20
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma. International journal of cancer. 2014 Academic Article GET IT
Times cited: 73
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era. Cancer. 2014 Academic Article GET IT
Times cited: 31
Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 55
The potential of theragnostic ¹²⁴I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma. Neuro-oncology. 2014 Academic Article GET IT
Times cited: 35
Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 94
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy. FEBS letters. 2013 Review GET IT
Times cited: 108
Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach. Journal of proteomics. 2013 Academic Article GET IT
Times cited: 13
Recurrent pre-existing and acquired DNA copy number alterations, including focal TERT gains, in neuroblastoma central nervous system metastases. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 21
Large traumatic pneumatocele in a 2-year-old child. Case reports in pediatrics. 2013 Academic Article GET IT
Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nature reviews. Cancer. 2013 Review GET IT
Times cited: 570
In silico driven redesign of a clinically relevant antibody for the treatment of GD2 positive tumors. PloS one. 2013 Academic Article GET IT
Times cited: 27
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody. Cancer. 2013 Academic Article GET IT
Times cited: 19
Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma. Oncoimmunology. 2013 Academic Article GET IT
Times cited: 305
Reply to L. Moreno et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Letter GET IT
Times cited: 1
Early negative minimal residual disease in bone marrow after immunotherapy is less predictive of late or non-marrow relapse among patients with high-risk stage 4 neuroblastoma. Pediatric blood & cancer. 2013 Academic Article GET IT
Times cited: 4
Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing data. Genome biology. 2012 Academic Article GET IT
Times cited: 25
5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma. Bone marrow transplantation. 2012 Academic Article GET IT
Times cited: 5
De novo engineering of a human cystathionine-γ-lyase for systemic (L)-Methionine depletion cancer therapy. ACS chemical biology. 2012 Academic Article GET IT
Times cited: 28
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature. Cancer. 2012 Review GET IT
Times cited: 37
Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 195
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. The Journal of clinical investigation. 2012 Academic Article GET IT
Times cited: 173
The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma. Cancer cell. 2012 Academic Article GET IT
Times cited: 231
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo. Oncoimmunology. 2012 Academic Article GET IT
Times cited: 14
Anti-CD3 × anti-GD2 bispecific antibody redirects T-cell cytolytic activity to neuroblastoma targets. Pediatric blood & cancer. 2012 Academic Article GET IT
Times cited: 54
ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy. Frontiers in oncology. 2012 Academic Article GET IT
Times cited: 192
Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA. 2012 Academic Article GET IT
Times cited: 320
Seatbelt: a double-edged sword. 2012 GET IT
A three-gene expression signature model for risk stratification of patients with neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 49
Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colony-stimulating factor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 49
Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor. Cancer gene therapy. 2011 Academic Article GET IT
Times cited: 56
MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2011 Academic Article GET IT
Times cited: 64
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma. Pediatric blood & cancer. 2011 Academic Article GET IT
Times cited: 25
Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G1 checkpoint-defective neuroblastoma. International journal of cancer. 2011 Academic Article GET IT
Times cited: 32
High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecan. Pediatric blood & cancer. 2011 Academic Article GET IT
Times cited: 24
Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 48
Impact of minimal tumor burden on antibody response to vaccination. Cancer immunology, immunotherapy : CII. 2011 Academic Article GET IT
Times cited: 13
Resectability and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral arteries. Journal of pediatric surgery. 2011 Academic Article GET IT
Times cited: 36
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma. Molecular cancer. 2010 Academic Article GET IT
Times cited: 48
Two-compartment model of radioimmunotherapy delivered through cerebrospinal fluid. European journal of nuclear medicine and molecular imaging. 2010 Academic Article GET IT
Times cited: 12
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastoma. European journal of cancer (Oxford, England : 1990). 2010 Academic Article GET IT
Times cited: 17
Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections. Journal of pediatric surgery. 2010 Academic Article GET IT
Times cited: 38
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma. Pediatric blood & cancer. 2010 Academic Article GET IT
Times cited: 6
Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma. Cancer. 2010 Academic Article GET IT
Times cited: 36
Interstitial infusion of glioma-targeted recombinant immunotoxin 8H9scFv-PE38. Molecular cancer therapeutics. 2010 Academic Article GET IT
Times cited: 29
Neuroblastoma: Therapeutic strategies for a clinical enigma. Cancer treatment reviews. 2010 Review GET IT
Times cited: 144
Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma. International journal of radiation oncology, biology, physics. 2010 Academic Article GET IT
Times cited: 12
Small-molecule ligands of GD2 ganglioside, designed from NMR studies, exhibit induced-fit binding and bioactivity. Chemistry & biology. 2010 Academic Article GET IT
Times cited: 11
High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Academic Article GET IT
Times cited: 131
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy. 2009 GET IT
Times cited: 3
Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma. Proceedings of the National Academy of Sciences of the United States of America. 2009 Academic Article GET IT
Times cited: 166
KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 101
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma. Journal of neuro-oncology. 2009 Academic Article GET IT
Times cited: 182
Enteric neural crest differentiation in ganglioneuromas implicates Hedgehog signaling in peripheral neuroblastic tumor pathogenesis. PloS one. 2009 Academic Article GET IT
Times cited: 21
Reducing epitope spread during affinity maturation of an anti-ganglioside GD2 antibody. Journal of immunology (Baltimore, Md. : 1950). 2009 Academic Article GET IT
Times cited: 14
Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study. Journal of the National Cancer Institute. 2009 Academic Article GET IT
Times cited: 142
A pharmacokinetic model for radioimmunotherapy delivered through cerebrospinal fluid for the treatment of leptomeningeal metastases. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2009 Academic Article GET IT
Times cited: 12
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Cancer research. 2009 Academic Article GET IT
Times cited: 223
Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma. Pediatric blood & cancer. 2009 Academic Article GET IT
Times cited: 36
Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer. Lung cancer (Amsterdam, Netherlands). 2009 Academic Article GET IT
Times cited: 4
Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma. International journal of radiation oncology, biology, physics. 2009 Academic Article GET IT
Times cited: 7
Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs. International journal of cancer. 2009 Academic Article GET IT
Times cited: 46
Monoclonal antibody therapies for solid tumors. Expert opinion on biological therapy. 2009 Review GET IT
Times cited: 19
Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma. BMC cancer. 2009 Academic Article GET IT
Times cited: 23
Lack of early bevacizumab-related skeletal radiographic changes in children with neuroblastoma. Pediatric blood & cancer. 2009 Letter GET IT
Times cited: 5
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 65
Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytes. Human gene therapy. 2009 Academic Article GET IT
Times cited: 42
Intraparenchymal and intratumoral interstitial infusion of anti-glioma monoclonal antibody 8H9. Neurosurgery. 2008 Academic Article GET IT
Times cited: 15
Management and outcome of stage 3 neuroblastoma. European journal of cancer (Oxford, England : 1990). 2008 Academic Article GET IT
Times cited: 37
Reconstructing the disease model and epigenetic networks for MLL-AF4 leukemia. Cancer cell. 2008 Comment GET IT
Times cited: 15
Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 59
Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomide. 2008 GET IT
Times cited: 11
Solitary relapse of desmoplastic small round cell tumor detected by positron emission tomography/computed tomography. 2008 GET IT
Times cited: 12
Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status. BMC medical genomics. 2008 Academic Article GET IT
Evaluation of widely consumed botanicals as immunological adjuvants. Vaccine. 2008 Academic Article GET IT
Times cited: 50
Brain-sparing radiotherapy for neuroblastoma skull metastases. Pediatric blood & cancer. 2008 Academic Article GET IT
Times cited: 10
Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy. Pediatric blood & cancer. 2008 Academic Article GET IT
Times cited: 37
Neuroblastoma--linking a common allele to a rare disease. The New England journal of medicine. 2008 Editorial Article GET IT
Times cited: 5
Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome. 2008 GET IT
Times cited: 14
Novel markers of subclinical disease for Ewing family tumors from gene expression profiling. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 54
Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 107
Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility. Oncogene. 2007 Academic Article GET IT
Times cited: 84
Induction for high-risk neuroblastoma. Pediatric blood & cancer. 2007 Comment GET IT
Times cited: 6
Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma. Genes, chromosomes & cancer. 2007 Academic Article GET IT
Times cited: 8
Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma. The Journal of molecular diagnostics : JMD. 2007 Academic Article GET IT
Times cited: 21
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy. Pediatric blood & cancer. 2007 Academic Article GET IT
Times cited: 20
The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma. Molecular cancer therapeutics. 2007 Academic Article GET IT
Times cited: 38
Disialoganglioside directed immunotherapy of neuroblastoma. Cancer investigation. 2007 Review GET IT
Times cited: 103
Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma. Health physics. 2007 Academic Article GET IT
Times cited: 10
Exploiting the MIBG-avidity of neuroblastoma for staging and treatment. Pediatric blood & cancer. 2006 Comment GET IT
Times cited: 11
Irinotecan plus temozolomide for relapsed or refractory neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 110
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma. Cancer. 2006 Academic Article GET IT
Times cited: 121
Sialyltransferase STX (ST8SiaII): a novel molecular marker of metastatic neuroblastoma. International journal of cancer. 2006 Academic Article GET IT
Times cited: 39
Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer research. 2006 Academic Article GET IT
Times cited: 165
FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 98
What factors predict a favorable outcome in young children with disseminated neuroblastoma?. Nature clinical practice. Oncology. 2006 Academic Article GET IT
Times cited: 2
Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients. Pediatric blood & cancer. 2006 Academic Article GET IT
Times cited: 16
The MYCN enigma: significance of MYCN expression in neuroblastoma. Cancer research. 2006 Academic Article GET IT
Times cited: 75
Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system. Bone marrow transplantation. 2006 Academic Article GET IT
Times cited: 29
Prognostic value of MYCN and ID2 overexpression in neuroblastoma. Pediatric blood & cancer. 2005 Academic Article GET IT
Times cited: 14
Neuroblastoma--from genetic profiles to clinical challenge. The New England journal of medicine. 2005 Comment GET IT
Times cited: 24
Complement-mediated mechanisms in anti-GD2 monoclonal antibody therapy of murine metastatic cancer. Cancer research. 2005 Academic Article GET IT
Times cited: 63
Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9. Cancer biotherapy & radiopharmaceuticals. 2005 Academic Article GET IT
Times cited: 31
Long-term complications in survivors of advanced stage neuroblastoma. Pediatric blood & cancer. 2005 Academic Article GET IT
Times cited: 140
Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucan. Leukemia research. 2005 Academic Article GET IT
Times cited: 68
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer research. 2005 Academic Article GET IT
Times cited: 129
Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma. Cancer. 2005 Academic Article GET IT
Times cited: 27
Antibody-based targeted radiation to pediatric tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2005 Review GET IT
Times cited: 25
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 100
Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis. Cancer. 2004 Academic Article GET IT
Times cited: 13
Favorable-biology neuroblastoma presenting with leptomeningeal metastases?: a case presentation. 2004 GET IT
Times cited: 3
Treatment reduction for neuroblastoma. Pediatric blood & cancer. 2004 Comment GET IT
Times cited: 2
Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas. Cancer genetics and cytogenetics. 2004 Academic Article GET IT
Times cited: 22
Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 41
Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours. British journal of cancer. 2004 Academic Article GET IT
Times cited: 9
Malignant pheochromocytoma: current status and initiatives for future progress. Endocrine-related cancer. 2004 Review GET IT
Times cited: 293
Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. Journal of the National Cancer Institute. 2004 Academic Article GET IT
Times cited: 110
Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. Journal of immunology (Baltimore, Md. : 1950). 2004 Academic Article GET IT
Times cited: 394
Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2004 Academic Article GET IT
Times cited: 54
The impact of gross total resection on local control and survival in high-risk neuroblastoma. Journal of pediatric surgery. 2004 Academic Article GET IT
Times cited: 160
In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma. Cancer research. 2004 Academic Article GET IT
Times cited: 61
Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 39
Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia (New York, N.Y.). 2004 Academic Article GET IT
Times cited: 182
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2004 Academic Article GET IT
Times cited: 112
Radically different treatment recommendations for newly diagnosed neuroblastoma: pitfalls in assessment of risk. 2004 GET IT
Times cited: 19
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience. Medical and pediatric oncology. 2003 Academic Article GET IT
Times cited: 70
Treatment of spinal involvement in neuroblastoma patients. Pediatric neurosurgery. 2003 Academic Article GET IT
Times cited: 38
Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing. 2003 GET IT
Times cited: 55
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003 Review GET IT
Times cited: 165
Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 44
Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapy. Hybridoma and hybridomics. 2003 Academic Article GET IT
Times cited: 19
Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer research. 2003 Academic Article GET IT
Times cited: 73
Oral topotecan for refractory and relapsed neuroblastoma: a retrospective analysis. Journal of pediatric hematology/oncology. 2003 Academic Article GET IT
Times cited: 25
Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma. Cancer letters. 2003 Review GET IT
Times cited: 28
Curability of recurrent disseminated disease after surgery alone for local-regional neuroblastoma using intensive chemotherapy and anti-G(D2) immunotherapy. Journal of pediatric hematology/oncology. 2003 Academic Article GET IT
Times cited: 22
Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification. 2003 GET IT
Times cited: 23
Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers. Medical and pediatric oncology. 2003 Academic Article GET IT
Times cited: 34
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 61
Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 46
Autoantigen diversity in the opsoclonus-myoclonus syndrome. Annals of neurology. 2003 Academic Article GET IT
Times cited: 127
Should we replace bone scintigraphy plus CT with MR imaging for staging of neuroblastoma?. Radiology. 2003 Letter GET IT
Times cited: 4
Anti-idiotypic antibody as the surrogate antigen for cloning scFv and its fusion proteins. Hybridoma and hybridomics. 2002 Academic Article GET IT
Times cited: 7
Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor. Medical and pediatric oncology. 2002 Academic Article GET IT
Times cited: 48
Risks outweighed benefits from local radiation for non-stage 4 neuroblastoma. International journal of radiation oncology, biology, physics. 2002 Letter GET IT
Times cited: 3
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer immunology, immunotherapy : CII. 2002 Academic Article GET IT
Times cited: 160
Chronic neuroblastoma. Cancer. 2002 Academic Article GET IT
Times cited: 24
Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8. Cancer. 2002 Academic Article GET IT
Times cited: 20
Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma. Cancer. 2002 Academic Article GET IT
Times cited: 23
Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2002 Academic Article GET IT
Times cited: 89
Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6. Proceedings of the National Academy of Sciences of the United States of America. 2002 Academic Article GET IT
Times cited: 46
Novel regions of allelic imbalance identified by genome-wide analysis of neuroblastoma. Cancer research. 2002 Academic Article GET IT
Times cited: 21
Expression of SSX-2 and SSX-4 genes in neuroblastoma. The International journal of biological markers. 2002 Academic Article GET IT
Times cited: 7
Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 175
Monoclonal antibody-based therapy of neuroblastoma. Hematology/oncology clinics of North America. 2001 Review GET IT
Times cited: 32
Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer research. 2001 Academic Article GET IT
Times cited: 77
Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults. Bone marrow transplantation. 2001 Academic Article GET IT
Times cited: 55
GD2 synthase: a new molecular marker for detecting neuroblastoma. Cancer. 2001 Academic Article GET IT
Times cited: 31
Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reaction. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 20
Genetic heterogeneity and clonal evolution in neuroblastoma. British journal of cancer. 2001 Academic Article GET IT
Times cited: 34
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 154
Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 105
Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 75
Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors. Cancer research. 2001 Academic Article GET IT
Times cited: 124
Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Academic Article GET IT
Times cited: 49
Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and A Literature Review. Cancer. 2001 Review GET IT
Times cited: 118
Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease. Cancer. 2001 Academic Article GET IT
Times cited: 23
Antibody-based diagnostic and therapeutic innovations for human cancer. Comprehensive therapy. 2001 Review GET IT
Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE. Medical and pediatric oncology. 2001 Academic Article GET IT
Times cited: 24
Disaloganglioside GD2 loss following monoclonal antibody therapy is rare in neuroblastoma. 2001 GET IT
Times cited: 27
Molecular genetics of neuroblastoma and the implications for clinical management: a review of the MSKCC experience. The oncologist. 2001 Review GET IT
Times cited: 15
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Medical and pediatric oncology. 2001 Academic Article GET IT
Times cited: 110
Correlation of anti-idiotype network with survival following anti-G(D2) monoclonal antibody 3F8 therapy of stage 4 neuroblastoma. Medical and pediatric oncology. 2000 Academic Article GET IT
Times cited: 23
Laser-capture microdissected schwannian and neuroblastic cells in stage 4 neuroblastomas have the same genetic alterations. Medical and pediatric oncology. 2000 Academic Article GET IT
Times cited: 11
Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastoma. Medical and pediatric oncology. 2000 Academic Article GET IT
Times cited: 24
Prognostic significance of GAGE detection in bone marrows on survival of patients with metastatic neuroblastoma. Medical and pediatric oncology. 2000 Academic Article GET IT
Times cited: 26
Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8. Medical and pediatric oncology. 2000 Academic Article GET IT
Times cited: 32
Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma. Cancer. 2000 Academic Article GET IT
Times cited: 17
Monoclonal antibody-based therapy for neuroblastoma. Current oncology reports. 2000 Review GET IT
Times cited: 18
Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors. Medical and pediatric oncology. 2000 Academic Article GET IT
Times cited: 65
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America. 2000 Academic Article GET IT
Times cited: 85
Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors. Cancer immunology, immunotherapy : CII. 2000 Academic Article GET IT
Times cited: 56
Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2000 Academic Article GET IT
Times cited: 71
CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma. Cancer research. 2000 Academic Article GET IT
Times cited: 53
Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. 2000 GET IT
Times cited: 95
Local control with multimodality therapy for stage 4 neuroblastoma. International journal of radiation oncology, biology, physics. 2000 Academic Article GET IT
Times cited: 68
Surface antigen expression and complement susceptibility of differentiated neuroblastoma clones. The American journal of pathology. 2000 Academic Article GET IT
Times cited: 24
Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p. The Journal of molecular diagnostics : JMD. 2000 Review GET IT
Times cited: 46
Detecting neuroblastoma using bone marrow aspiration and bone marrow biopsy. Journal of pediatric hematology/oncology. 2000 Letter GET IT
Times cited: 2
Clinically critical impact of molecular genetic studies in pediatric solid tumors. Medical and pediatric oncology. 1999 Academic Article GET IT
Times cited: 36
Oral etoposide for refractory and relapsed neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 49
Treatment of neoplastic meningeal xenografts by intraventricular administration of an antiganglioside monoclonal antibody, 3F8. International journal of cancer. 1999 Academic Article GET IT
Times cited: 11
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors. Nuclear medicine and biology. 1999 Academic Article GET IT
Times cited: 8
Association between molecular detection of GAGE and survival in patients with malignant melanoma: a retrospective cohort study. Clinical cancer research : an official journal of the American Association for Cancer Research. 1999 Academic Article GET IT
Times cited: 19
Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats. Journal of immunotherapy (Hagerstown, Md. : 1997). 1999 Academic Article GET IT
Times cited: 11
Detection of neuroblastoma in bone marrow by immunocytology: is a single marrow aspirate adequate?. Medical and pediatric oncology. 1999 Academic Article GET IT
Times cited: 12
Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis. 1999 GET IT
Times cited: 19
Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Review GET IT
Times cited: 76
Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers. Clinical cancer research : an official journal of the American Association for Cancer Research. 1998 Academic Article GET IT
Times cited: 67
Association of CYP3A4 genotype with treatment-related leukemia. Proceedings of the National Academy of Sciences of the United States of America. 1998 Academic Article GET IT
Times cited: 322
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 168
Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 1998 Academic Article GET IT
Times cited: 50
High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 68
Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes. The Journal of experimental medicine. 1998 Academic Article GET IT
Times cited: 224
Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases. Cancer research. 1998 Academic Article GET IT
Times cited: 99
3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study. International journal of oncology. 1998 Academic Article GET IT
Times cited: 89
In vitro antitumor activity of rebeccamycin analog (NSC# 655649) against pediatric solid tumors. Journal of pediatric hematology/oncology. 1998 Academic Article GET IT
Times cited: 21
Pharmacokinetics of IgG and IgM anti-ganglioside antibodies in rats and monkeys after intrathecal administration. The Journal of pharmacology and experimental therapeutics. 1998 Academic Article GET IT
Times cited: 29
Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells. Immunobiology. 1997 Academic Article GET IT
Times cited: 25
Pharmacokinetics and acute toxicology of intraventricular 131 I-monoclonal antibody targeting disialoganglioside in non-human primates. Journal of neuro-oncology. 1997 Academic Article GET IT
Times cited: 18
Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma. European journal of cancer (Oxford, England : 1990). 1997 Academic Article GET IT
Times cited: 22
Monoclonal antibody to human Trk-A: diagnostic and therapeutic potential in neuroblastoma. European journal of cancer (Oxford, England : 1990). 1997 Academic Article GET IT
Times cited: 14
Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers. European journal of cancer (Oxford, England : 1990). 1997 Academic Article GET IT
Times cited: 26
A rat model of leptomeningeal human neoplastic xenografts. Journal of neuro-oncology. 1997 Academic Article GET IT
Times cited: 6
Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Academic Article GET IT
Times cited: 76
Molecular detection of GAGE expression in peripheral blood and bone marrow: utility as a tumor marker for neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 1997 Academic Article GET IT
Times cited: 71
Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery. Annals of surgical oncology. 1996 Academic Article GET IT
Times cited: 36
Small molecule nerve growth factor analogs image receptors in vivo. Nature biotechnology. 1996 Academic Article GET IT
Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 1996 Academic Article GET IT
Times cited: 15
International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Review GET IT
Times cited: 42
Allelic loss of chromosome 1p in neuroblastoma. The New England journal of medicine. 1996 Letter GET IT
Times cited: 1
The p53 gene in pediatric therapy-related leukemia and myelodysplasia. Blood. 1996 Academic Article GET IT
Times cited: 75
Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 300
Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 98
Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial. European journal of nuclear medicine. 1996 Academic Article GET IT
Times cited: 42
Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta doses. Nuclear medicine and biology. 1996 Academic Article GET IT
Times cited: 26
Autologous bone marrow transplantation in children with advanced neuroblastoma. Cancer. 1995 Letter GET IT
Times cited: 2
Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor. Cancer immunology, immunotherapy : CII. 1995 Academic Article GET IT
Times cited: 24
GD2 oligosaccharide: target for cytotoxic T lymphocytes. The Journal of experimental medicine. 1995 Academic Article GET IT
Times cited: 47
Neonatal screening and management of biologically low-risk localized neuroblastoma. Journal of pediatric hematology/oncology. 1995 Letter GET IT
Times cited: 2
Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors. European journal of nuclear medicine. 1995 Academic Article GET IT
Times cited: 19
Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer. 1995 Academic Article GET IT
Times cited: 158
Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 158
Oral calcium treatment in vitamin D-dependent rickets type II. 1994 GET IT
Times cited: 9
Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. Journal of pediatric surgery. 1994 Academic Article GET IT
Times cited: 80
Current status of radioimmunotherapy. Nuclear medicine and biology. 1994 Academic Article GET IT
Times cited: 19
Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival. Cancer research. 1994 Academic Article GET IT
Times cited: 75
3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study. Progress in clinical and biological research. 1994 Academic Article GET IT
Times cited: 16
Clinical progress in neuroblastoma. Cancer investigation. 1994 Review GET IT
Times cited: 17
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification. Progress in clinical and biological research. 1994 Academic Article GET IT
Times cited: 4
Ganglioside gd(2) expression in the human nervous-system and in neuroblastomas - an immunohistochemical study. International journal of oncology. 1993 Academic Article GET IT
Rethinking management of localized neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Letter GET IT
Times cited: 3
Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas. Nature genetics. 1993 Academic Article GET IT
Times cited: 65
Disialoganglioside GD2 anti-idiotypic monoclonal antibodies. International journal of cancer. 1993 Academic Article GET IT
Times cited: 42
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma. European journal of nuclear medicine. 1993 Academic Article GET IT
Times cited: 48
Optimizing the recovery of chemically reduced monoclonal antibody for site-specific technetium-99m radiolabeling. BioTechniques. 1993 Academic Article GET IT
Times cited: 2
GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40tax. Proceedings of the National Academy of Sciences of the United States of America. 1993 Academic Article GET IT
Times cited: 55
Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8. Journal of neuro-oncology. 1993 Academic Article GET IT
Times cited: 8
Expression of disialogangliosides GD2 and GD3 on human soft tissue sarcomas. Cancer. 1992 Academic Article GET IT
Times cited: 84
Preclinical and clinical studies of macrophage colony-stimulating factor. Seminars in oncology. 1992 Review GET IT
Times cited: 17
Current therapies using monoclonal antibodies: I. Organ transplantation, bacterial sepsis, bone marrow transplantation. Comprehensive therapy. 1992 Review GET IT
Times cited: 2
Current therapies using monoclonal antibodies: II. Malignant disease. Comprehensive therapy. 1992 Review GET IT
Times cited: 4
Reassessment of patient response to monoclonal antibody 3F8. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Letter GET IT
Times cited: 25
Absolute requirement of CD11/CD18 adhesion molecules, FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity. Blood. 1992 Academic Article GET IT
Times cited: 83
A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies. International journal of cancer. 1992 Academic Article GET IT
Times cited: 26
Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes. Cancer research. 1991 Academic Article GET IT
Times cited: 44
Dose-intensity analysis and randomized trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Letter GET IT
Times cited: 2
High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma. Cancer. 1991 Academic Article GET IT
Times cited: 20
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The New England journal of medicine. 1991 Academic Article GET IT
Times cited: 2358
Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Review GET IT
Times cited: 203
Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1991 Academic Article GET IT
Times cited: 83
Immunotherapy. Neuroblastoma as a model. Pediatric clinics of North America. 1991 Review GET IT
Times cited: 22
Macrophage colony-stimulating factor: biological effects and potential applications for cancer therapy. Seminars in hematology. 1991 Review GET IT
Times cited: 18
Cyclophosphamide and the heart. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Letter GET IT
Times cited: 4
Role of low-affinity Fc receptors in antibody-dependent tumor cell phagocytosis by human monocyte-derived macrophages. Cancer research. 1991 Academic Article GET IT
Times cited: 41
Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 89
131I-3F8: clinical validation of imaging studies and therapeutic applications. Progress in clinical and biological research. 1991 Academic Article GET IT
Times cited: 6
Efficient killing of neuroblastoma cells by human monocytes activated with recombinant human macrophage colony-stimulating factor and anti-tumor antibody. Progress in clinical and biological research. 1991 Academic Article GET IT
Times cited: 2
Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial. Progress in clinical and biological research. 1991 Academic Article GET IT
Times cited: 27
Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy. Medical physics. 1991 Academic Article GET IT
Times cited: 91
Stage IV neuroblastoma more than 1 year of age at diagnosis: major response to chemotherapy and survival durations correlated strongly with dose intensity. Progress in clinical and biological research. 1991 Academic Article GET IT
Times cited: 11
Technical challenges associated with the radiolabeling of monoclonal antibodies utilizing short-lived, positron emitting radionuclides. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology. 1991 Review GET IT
Times cited: 12
Complement killing of human neuroblastoma cells: a cytotoxic monoclonal antibody and its F(ab')2-cobra venom factor conjugate are equally cytotoxic. Molecular immunology. 1990 Academic Article GET IT
Times cited: 38
Dose-intensive use of cyclophosphamide in ablation of neuroblastoma. Cancer. 1990 Academic Article GET IT
Times cited: 52
Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2. Cancer research. 1990 Academic Article GET IT
Times cited: 154
Cyclophosphamide versus ifosfamide in paediatric oncology. Lancet (London, England). 1990 Letter GET IT
Times cited: 3
Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. The Journal of experimental medicine. 1990 Academic Article GET IT
Times cited: 121
Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates. Blood. 1990 Academic Article GET IT
Times cited: 81
Autografting with bone marrow exposed to multiple courses of very high dose cyclophosphamide in vivo and to 4-hydroperoxycyclophosphamide in vitro. Medical and pediatric oncology. 1990 Academic Article GET IT
Times cited: 10
Monoclonal antibody 3F8 recognises the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2. British journal of cancer. 1989 Academic Article GET IT
Times cited: 19
Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays. The Journal of experimental medicine. 1989 Academic Article GET IT
Times cited: 128
GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood. 1989 Academic Article GET IT
Times cited: 164
Biodistribution and dosimetry of 3F8 neuroblastoma monoclonal antibody. American journal of physiologic imaging. 1989 Academic Article GET IT
Times cited: 1
Comparison of radiolabeled monoclonal antibody and magnetic resonance imaging in the detection of metastatic neuroblastoma in bone marrow: preliminary results. Pediatric radiology. 1989 Academic Article GET IT
Times cited: 10
In vitro chemopurification of neuroblastoma cells: comparison of 6-hydroxydopamine and ascorbic acid with 4-hydroperoxycyclophosphamide. Cancer investigation. 1989 Academic Article GET IT
Times cited: 8
Targeted radiotherapy and immunotherapy of human neuroblastoma with GD2 specific monoclonal antibodies. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology. 1989 Review GET IT
Times cited: 11
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. The Journal of clinical investigation. 1988 Academic Article GET IT
Times cited: 124
High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Blood. 1988 Academic Article GET IT
Times cited: 77
Neuroblastoma. Pediatric annals. 1988 Review GET IT
Times cited: 14
Immunotherapy with GD2 specific monoclonal antibodies. Progress in clinical and biological research. 1988 Review GET IT
Times cited: 16
In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study. Progress in clinical and biological research. 1988 Academic Article GET IT
Times cited: 9
Iodine 131 labeled GD2 monoclonal antibody in the diagnosis and therapy of human neuroblastoma. Progress in clinical and biological research. 1988 Academic Article GET IT
Times cited: 15
Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma. Cancer research. 1987 Academic Article GET IT
Times cited: 135
Localization of GD2-specific monoclonal antibody 3F8 in human osteosarcoma. Cancer research. 1987 Academic Article GET IT
Times cited: 95
Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients. Transplantation. 1987 Academic Article GET IT
Times cited: 13
Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1987 Academic Article GET IT
Times cited: 41
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Times cited: 353
An assessment of monocyte procoagulant activity in patients with solid tumors. The Journal of surgical research. 1987 Academic Article GET IT
Times cited: 31
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation. Seminars in oncology. 1987 Academic Article GET IT
Times cited: 6
Stomatologic complications of bone marrow transplantation in a pediatric population. Pediatric dentistry. 1987 Academic Article GET IT
Times cited: 37
Diagnostic imaging of human neuroblastoma with radiolabeled antibody. Radiology. 1986 Academic Article GET IT
Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice. Journal of the National Cancer Institute. 1986 Academic Article GET IT
Times cited: 107
Surgical endoscopy training in a university program. The American surgeon. 1986 Academic Article GET IT
Times cited: 3
Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies. 1986 GET IT
Times cited: 75
Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow. Cancer research. 1985 Academic Article GET IT
Times cited: 57
Preoperative intra-arterial infusion chemotherapy for advanced squamous cell carcinoma of the mouth and oropharynx. Cancer. 1985 Academic Article GET IT
Times cited: 23
Underestimation of specific immunoglobulin E by microtiter plate enzyme-linked immunosorbent assays. The Journal of allergy and clinical immunology. 1985 Academic Article GET IT
Times cited: 21
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation. Seminars in oncology. 1985 Academic Article GET IT
Times cited: 21
Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer research. 1985 Academic Article GET IT
Times cited: 288
Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell. Biochemical and biophysical research communications. 1985 Academic Article GET IT
Times cited: 93
Development of neuroblastoma monoclonal antibodies for potential utilization in diagnosis and therapy. Progress in clinical and biological research. 1985 Academic Article GET IT
Times cited: 9
Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients. The American journal of pediatric hematology/oncology. 1985 Academic Article GET IT
Times cited: 16
Multimodality preoperative treatment for advanced cancer of the head and neck. American journal of surgery. 1984 Academic Article GET IT
Times cited: 15
Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients. Blood. 1984 Academic Article GET IT
Times cited: 37
Von Haberer-Finney gastrectomy revisited. The American surgeon. 1984 Academic Article GET IT
Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood. 1983 Academic Article GET IT
Times cited: 257
Radioimmunoassays for specific human IgG4. Clinical reviews in allergy. 1983 Academic Article GET IT
Times cited: 1
A microtiter solid-phase radioimmunoassay for platelet-associated immunoglobulin G. The Journal of laboratory and clinical medicine. 1983 Academic Article GET IT
Times cited: 10
Honey bee venom specific immunoglobulin G4 in honey bee sting allergic patients and bee keepers. Annals of allergy. 1983 Academic Article GET IT
Times cited: 19
Platelet-associated immunoglobulin G in childhood idiopathic thrombocytopenic purpura. The Journal of pediatrics. 1983 Academic Article GET IT
Times cited: 20
Reduction of interference by specific IgG with a modified microtiter solid-phase radioimmunoassay to measure honeybee venom IgE. The Journal of allergy and clinical immunology. 1983 Academic Article GET IT
Times cited: 6
A quantitative enzyme-linked immunosorbent assay for honeybee venom-specific immunoglobulin G. The Journal of allergy and clinical immunology. 1982 Academic Article GET IT
Times cited: 19
Global review of intrasplenic pancreatic pseudocysts: an additional case report using preoperative splenic artery embolization. 1982 GET IT
Times cited: 1
Microtiter solid-phase radioimmunoassay for specific immunoglobulin E. The Journal of allergy and clinical immunology. 1981 Academic Article GET IT
Times cited: 11
A microtiter solid phase radioimmunoassay for total serum IgE. Annals of allergy. 1981 Academic Article GET IT
Times cited: 13
Immune suppression in vivo with antigen-modified syngeneic cells. II. T cell-mediated nonresponsiveness to fowl gamma-globulin. Journal of immunology (Baltimore, Md. : 1950). 1979 Academic Article GET IT
Times cited: 26
Immune suppression in vivo with antigen-modified syngeneic cells. I. T-cell-mediated suppression to the terpolymer poly-(Glu, Lys, Phe)n. The Journal of experimental medicine. 1978 Academic Article GET IT
Times cited: 20
H-2 control of tolerance induction to L-glutamic acid, L-lysine-containing polymers. Journal of immunology (Baltimore, Md. : 1950). 1978 Academic Article GET IT
Times cited: 5
Pyogenic liver abscess. The American surgeon. 1978 Academic Article GET IT
Times cited: 11
Colon and rectal carcinoma: clinical experience. The American surgeon. 1977 Academic Article GET IT
Times cited: 3
Development of a hemolytic plaque assay for glutamic acid, lysine-containing polypeptides: demonstration that nonresponder mice produce antibodies to these peptides when conjugated to an immunogenic carrier. Journal of immunology (Baltimore, Md. : 1950). 1977 Academic Article GET IT
Times cited: 12

more ...

less ...

Background

education and training

M.D., Harvard Medical School 1978
Ph.D., Harvard University 1978
B.S., University of Chicago 1972

Contact

full name

Nai-Kong Cheung

VIVO Weill Cornell Medical College

Nai-Kong Cheung Associate Professor of Pediatrics

Publications

selected publications

Background

education and training

Contact

full name